Skip to content

The effect of pomegranate juice consumption on antioxidant and oxidant variables after exercise in young men.

The effect of pomegranate juice consumption on antioxidant and oxidant variables after exercise in young men.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201012255144N2
Enrollment
30
Registered
2011-09-17
Start date
2011-04-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic healthy individuals. Examination for participation in sport

Interventions

Intervention 1: Given 240 cc daily of pomegranate juice to interventional group for two weeks. Given once training until exhaustive status to interventional group. Intervention 2: Given 240 cc dail
Given 240 cc daily of pomegranate juice to interventional group for two weeks. Given once training until exhaustive status to interventional group.
Given 240 cc daily of tap water to control group for two weeks Given once training until exhaustive status to control group

Sponsors

Vice Chancellor for Research, Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria; healthy male students athlete, at age between 18 - 40 years old, living in Ardabil University of Medical Sciences Boarding. Exclusion criteria; people with have certain diseases, non-athletes, smoking, and consumption of other supplements.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Exhaustion time. Timepoint: At the end of once training. Method of measurement: The signs and symptoms related to the complete exhaustion.

Secondary

MeasureTime frame
Malondialdehyde. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectrophotometry.;Total antioxidant capacity. Timepoint: At the beginning and end of intervention. Method of measurement: Spectrophotometry.;Weight. Timepoint: At the beginning of intervention. Method of measurement: Digital scales.;Height. Timepoint: At the beginning intervention. Method of measurement: Stadiometers.;Glutathione. Timepoint: At the beginning and the end of intervention. Method of measurement: ELISA.;Total cholesterol. Timepoint: At the beginning and end of intervention. Method of measurement: Spectrophotometry.;Cu. Timepoint: At the beginning and the end of intervention. Method of measurement: Atomic absorption spectrophotometry.;Zn. Timepoint: At the beginning and the end of intervention. Method of measurement: Atomic absorption spectrophotometry.;Mg and . Timepoint: At the beginning and the end of intervention. Method of measurement: Atomic absorption spectrophotometry.;Fe. Timepoint: At the beginning and end of intervention. Method of measurement: Spectrophotometry.;Glutathione peroxidase. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectrophotometry.;Paraoxonase 1. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectophotometry.;Superoxide desmutase. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectrophotometry.;Matrix metalloproteinase 9. Timepoint: At the beginning and the end of intervention. Method of measurement: ELISA.;Ceruloplasmin. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectrophotometry.;LDL-C. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectrophotometry.;HDL-C. Timepoint: At the beginning and end of intervention. Method of measurement: Spectrophotometry.;Triglyceride. Timepoint: At the beginning and the end of intervention. Method of measurement: Spectrophoto

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026